| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A net-work meta-analysis of the cardiac safety for next-generation hormonal agents in treating castration-resistant prostate cancer: How to choose drugs appropriately?
|
Zhen, Liang
|
|
|
196 |
C |
p.
|
artikel
|
| 2 |
Cancer of unknown primary and the «seed and soil» hypothesis
|
Zolotykh, Mariya A.
|
|
|
196 |
C |
p.
|
artikel
|
| 3 |
Cardiovascular complications of ribociclib in breast cancer patients
|
Fiste, Oraianthi
|
|
|
196 |
C |
p.
|
artikel
|
| 4 |
Clinical characteristics associated with efficacy and prognosis among patients treated with PD-1/PD-L1 inhibitors for early-stage triple-negative breast cancers: A meta-analysis
|
Wei, Yuhan
|
|
|
196 |
C |
p.
|
artikel
|
| 5 |
Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions
|
Gerosa, Riccardo
|
|
|
196 |
C |
p.
|
artikel
|
| 6 |
Decoding the puzzle: A multidisciplinary systematic review of adult brainstem glioma
|
Ius, Tamara
|
|
|
196 |
C |
p.
|
artikel
|
| 7 |
Dietary restriction and hepatic cancer: Systematic review and meta-analysis of animal studies
|
de Sousa, Dallyla Jennifer Morais
|
|
|
196 |
C |
p.
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
196 |
C |
p.
|
artikel
|
| 9 |
Effect of non-pharmacological interventions on symptoms and quality of life in patients with hematological malignancies – A systematic review
|
Pedersen, Maja
|
|
|
196 |
C |
p.
|
artikel
|
| 10 |
Efficacy and safety of trastuzumab deruxtecan in treating human epidermal growth factor receptor 2-low/positive advanced breast cancer:A meta-analysis of randomized controlled trials
|
Ma, Rui
|
|
|
196 |
C |
p.
|
artikel
|
| 11 |
Efficacy of immune checkpoint inhibitors combinations as first-line systemic treatment in patients with advanced urothelial carcinoma: A systematic review and network meta-analysis
|
Monteiro, Fernando Sabino Marques
|
|
|
196 |
C |
p.
|
artikel
|
| 12 |
Efficacy of PD-1/PD-L1 immunotherapy on brain metastatic non-small-cell lung cancer and treatment-related adverse events: A systematic review
|
Phillips, William
|
|
|
196 |
C |
p.
|
artikel
|
| 13 |
Filgrastim biosimilar (EP2006): A review of 15 years’ post-approval evidence
|
Gascón, Pere
|
|
|
196 |
C |
p.
|
artikel
|
| 14 |
Higher risk of hepatotoxicity associated with cabozantinib in cancer patients
|
Wang, Zhen
|
|
|
196 |
C |
p.
|
artikel
|
| 15 |
Immune therapies of B-cell acute lymphoblastic leukaemia in children and adults
|
Kegyes, David
|
|
|
196 |
C |
p.
|
artikel
|
| 16 |
Impact of smoking cessation duration on lung cancer mortality: A systematic review and meta-analysis
|
Lai, Hongkun
|
|
|
196 |
C |
p.
|
artikel
|
| 17 |
Incidence of antibody–drug conjugate-related fatigue in patients with breast cancer: A systematic review and meta-analysis
|
Zhang, Hengheng
|
|
|
196 |
C |
p.
|
artikel
|
| 18 |
Involvement of CircRNAs in regulating The “New Generation of Cancer Hallmarks”: A Special Depiction on Hepatocellular Carcinoma
|
Dawoud, A.
|
|
|
196 |
C |
p.
|
artikel
|
| 19 |
Killing two birds with one stone: Abscopal effect mechanism and its application prospect in radiotherapy
|
Yu, Boyi
|
|
|
196 |
C |
p.
|
artikel
|
| 20 |
Long noncoding RNA expression in acute lymphoblastic leukemia: A systematic review
|
Lobo-Alves, Sara Cristina
|
|
|
196 |
C |
p.
|
artikel
|
| 21 |
Mapping the research landscape of HPV-positive oropharyngeal cancer: a bibliometric analysis
|
Ammirabile, Angela
|
|
|
196 |
C |
p.
|
artikel
|
| 22 |
Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies
|
Liu, Weici
|
|
|
196 |
C |
p.
|
artikel
|
| 23 |
Neoadjuvant therapy in renal cell carcinoma with tumor thrombus: A systematic review and meta-analysis
|
Gu, Liangyou
|
|
|
196 |
C |
p.
|
artikel
|
| 24 |
Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated myelodysplastic syndrome: A systematic review and meta-analysis
|
Shahzad, Moazzam
|
|
|
196 |
C |
p.
|
artikel
|
| 25 |
Patients’ selection and trial matching in early-phase oncology clinical trials
|
Corbaux, P.
|
|
|
196 |
C |
p.
|
artikel
|
| 26 |
Physical activity for cancer prehabilitation: A scoping review
|
Yang, Lin
|
|
|
196 |
C |
p.
|
artikel
|
| 27 |
Rethinking treatment paradigms: Neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer
|
Bouassaly, Jenna
|
|
|
196 |
C |
p.
|
artikel
|
| 28 |
Second-line treatment options in metastatic castration-resistant prostate cancer after progression on first-line androgen-receptor targeting therapies: A systematic review and Bayesian network analysis
|
Xiong, Xingyu
|
|
|
196 |
C |
p.
|
artikel
|
| 29 |
Should we use nomograms for risk predictions in diffuse large B cell lymphoma patients? A systematic review
|
Jelicic, Jelena
|
|
|
196 |
C |
p.
|
artikel
|
| 30 |
Targeted immunotherapy to cancer stem cells: A novel strategy of anticancer immunotherapy
|
Yi, Shan-Yong
|
|
|
196 |
C |
p.
|
artikel
|
| 31 |
The association between paraneoplastic neurological syndromes (PNS) and urothelial carcinoma – A review of the literature
|
Otis, Sarafina Urenna
|
|
|
196 |
C |
p.
|
artikel
|
| 32 |
The cytokines in tumor microenvironment: from cancer initiation-elongation-progression to metastatic outgrowth
|
Pradhan, Rajalaxmi
|
|
|
196 |
C |
p.
|
artikel
|
| 33 |
The role of angiogenesis inhibitors associated with tyrosine kinase inhibitors in the first-line treatment for EGFR-mutated advanced lung cancer
|
Motta-Guerrero, Rodrigo
|
|
|
196 |
C |
p.
|
artikel
|
| 34 |
The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategies
|
Ferro, Alessandra
|
|
|
196 |
C |
p.
|
artikel
|
| 35 |
The treatment of advanced melanoma: Current approaches and new challenges
|
Boutros, Andrea
|
|
|
196 |
C |
p.
|
artikel
|
| 36 |
Tumor-associated macrophages in non-small-cell lung cancer: From treatment resistance mechanisms to therapeutic targets
|
Huang, Zhenjun
|
|
|
196 |
C |
p.
|
artikel
|
| 37 |
UGT1A1 Testing in Breast Cancer: should it become routine practice in patients treated with antibody-drug conjugates?
|
Ibrahim, Rebecca
|
|
|
196 |
C |
p.
|
artikel
|
| 38 |
Uncovering the bookshelves of CRISPR-based libraries: Advances and applications in cancer studies
|
Quintero-Ruiz, Nathalia
|
|
|
196 |
C |
p.
|
artikel
|
| 39 |
Unraveling molecular signatures in rare bone tumors and navigating the cancer pathway landscapes for targeted therapeutics
|
Wani, Atif Khurshid
|
|
|
196 |
C |
p.
|
artikel
|
| 40 |
Updated review on analysis of long non-coding RNAs as emerging diagnostic and therapeutic targets in prostate cancers
|
Ke, Zongpan
|
|
|
196 |
C |
p.
|
artikel
|
| 41 |
US physician perspective on the use of biomarker and ctDNA testing in patients with melanoma
|
Fischer, Rachel A.
|
|
|
196 |
C |
p.
|
artikel
|
| 42 |
Vascular access device type for systemic anti-cancer therapies in cancer patients: A scoping review
|
Duggan, C.
|
|
|
196 |
C |
p.
|
artikel
|
Tijdschrift beschrijving